|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Dyba T, Randi G, Bettio M, Gavin A, Visser O and Bray F: Cancer
incidence and mortality patterns in Europe: Estimates for 40
countries and 25 major cancers in 2018. Eur J Cancer. 103:356–387.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kleberg K, Jensen GM, Christensen DP,
Lundh M, Grunnet LG, Knuhtsen S, Poulsen SS, Hansen MB and Bindslev
N: Transporter function and cyclic AMP turnover in normal colonic
mucosa from patients with and without colorectal neoplasia. BMC
Gastroenterol. 12:782012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rawłuszko-Wieczorek AA, Horst N, Horbacka
K, Bandura AS, Świderska M, Krokowicz P and Jagodziński PP: Effect
of DNA methylation profile on OATP3A1 and OATP4A1 transcript levels
in colorectal cancer. Biomed Pharmacother. 74:233–242. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stieger B and Hagenbuch B: Organic
anion-transporting polypeptides. Curr Top Membr. 73:205–232. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hagenbuch B and Stieger B: The SLCO
(former SLC21) superfamily of transporters. Mol Aspects Med.
34:396–412. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Svoboda M, Riha J, Wlcek K, Jaeger W and
Thalhammer T: Organic anion transporting polypeptides (OATPs):
Regulation of expression and function. Curr Drug Metab. 12:139–153.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Obaidat A, Roth M and Hagenbuch B: The
expression and function of organic anion transporting polypeptides
in normal tissues and in cancer. Annu Rev Pharmacol Toxicol.
52:135–151. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
König J: Uptake transporters of the human
OATP family: Molecular characteristics, substrates, their role in
drug-drug interactions, and functional consequences of
polymorphisms. Handb Exp Pharmacol. 1–28. 2011.doi:
10.1007/978-3-642-14541-4_1. View Article : Google Scholar
|
|
9
|
Patik I, Kovacsics D, Német O, Gera M,
Várady G, Stieger B, Hagenbuch B, Szakács G and Özvegy-Laczka C:
Functional expression of the 11 human organic anion transporting
polypeptides in insect cells reveals that sodium fluorescein is a
general OATP substrate. Biochem Pharmacol. 98:649–658. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schuster VL: Prostaglandin transport.
Prostaglandins Other Lipid Mediat. 68-69:633–647. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nguyen TT, Ung TT, Kim NH and Jung YD:
Role of bile acids in colon carcinogenesis. World J Clin Cases.
6:577–588. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gilligan LC, Gondal A, Tang V, Hussain MT,
Arvaniti A, Hewitt AM and Foster PA: Estrone sulfate transport and
steroid sulfatase activity in colorectal cancer: Implications for
hormone replacement therapy. Front Pharmacol. 8:1032017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen C, Gong X, Yang X, Shang X, Du Q,
Liao Q, Xie R, Chen Y and Xu J: The roles of estrogen and estrogen
receptors in gastrointestinal disease. Oncol Lett. 18:5673–5680.
2019.PubMed/NCBI
|
|
14
|
Lavasani S, Chlebowski RT, Prentice RL,
Kato I, Wactawski-Wende J, Johnson KC, Young A, Rodabough R,
Hubbell FA, Mahinbakht A and Simon MS: Estrogen and colorectal
cancer incidence and mortality. Cancer. 121:3261–3271. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Buxhofer-Ausch V, Secky L, Wlcek K,
Svoboda M, Kounnis V, Briasoulis E, Tzakos AG, Jaeger W and
Thalhammer T: Tumor-specific expression of organic
anion-transporting polypeptides: Transporters as novel targets for
cancer therapy. J Drug Deliv. 2013:8635392013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Buxhofer-Ausch V, Sheikh M, Ausch C,
Zotter S, Bauer H, Mollik M, Reiner A, Gleiss A, Jäger W, Sebesta
C, et al: Abundance of the Organic Anion-transporting Polypeptide
OATP4A1 in Early-stage colorectal cancer patients: Association with
disease relapse. Appl Immunohistochem Mol Morphol. 27:185–194.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ban MJ, Ji SH, Lee CK, Bae SB, Kim HJ, Ahn
TS, Lee MS, Baek MJ and Jeong D: Solute carrier organic anion
transporter family member 4A1 (SLCO4A1) as a prognosis marker of
colorectal cancer. J Cancer Res Clin Oncol. 143:1437–1447. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee HH and Ho RH: Interindividual and
interethnic variability in drug disposition: Polymorphisms in
organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1). Br J
Clin Pharmacol. 83:1176–1184. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kalliokoski A and Niemi M: Impact of OATP
transporters on pharmacokinetics. Br J Pharmacol. 158:693–705.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang B and Lauschke VM: Genetic
variability and population diversity of the human SLCO (OATP)
transporter family. Pharmacol Res. 139:550–559. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee W, Belkhiri A, Lockhart AC, Merchant
N, Glaeser H, Harris EI, Washington MK, Brunt EM, Zaika A, Kim RB
and El-Rifai W: Overexpression of OATP1B3 confers apoptotic
resistance in colon cancer. Cancer Res. 68:10315–10323. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Falkowski S, Woillard JB, Postil D,
Tubiana-Mathieu N, Terrebonne E, Pariente A, Smith D, Guimbaud R,
Thalamas C, Rouguieg-Malki K, et al: Common variants in
glucuronidation enzymes and membrane transporters as potential risk
factors for colorectal cancer: A case control study. BMC Cancer.
17:9012017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Evangeli L, Ioannis S, Valentinos K,
Antigony M, Elli I, Eleftheria H, Vasiliki G and Evangelos B:
SLCO1B3 screening in colorectal cancer patients using
High-Resolution Melting Analysis method and immunohistochemistry.
Tumour Biol. 39:10104283176911762017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
UICC (International Union Against Cancer).
TNM Classification of Malignant Tumors. Sobin LH, Gospodarowicz MK
and Wittekind CH: 7th. Blackwell, Oxford: pp. 252010
|
|
25
|
https://www.ris.bka.gv.at/eli/lgbl/WI/1987/23/P15a/LWI40012343Aug
5–2020
|
|
26
|
Fischer AH, Jacobson KA, Rose J and Zeller
R: Hematoxylin and eosin staining of tissue and cell sections. CSH
Protoc. May 1–2008.(Epub ahead of print). doi:
10.1101/pdb.prot4986.
|
|
27
|
Slatkin M: Linkage
disequilibrium-understanding the evolutionary past and mapping the
medical future. Nat Rev Genet. 9:477–485. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Machiela MJ and Chanock SJ: LDlink: A
web-based application for exploring population-specific haplotype
structure and linking correlated alleles of possible functional
variants. Bioinformatics. 31:3555–3557. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rogojanu R, Thalhammer T, Thiem U, Heindl
A, Mesteri I, Seewald A, Jäger W, Smochina C, Ellinger I and Bises
G: Quantitative image analysis of epithelial and stromal area in
histological sections of colorectal cancer: An emerging diagnostic
tool. BioMed Res Int. 2015:5690712015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Haisan A, Rogojanu R, Croitoru C, Jitaru
D, Tarniceriu C, Danciu M and Carasevici E: Digital microscopy
assessment of angiogenesis in different breast cancer compartments.
BioMed Res Int. 2013:2869022013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kolacsek O, Krízsik V, Schamberger A,
Erdei Z, Apáti A, Várady G, Mátés L, Izsvák Z, Ivics Z, Sarkadi B
and Orbán TI: Reliable transgene-independent method for determining
sleeping beauty transposon copy numbers. Mob DNA. 2:52011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gál C, Hegedüs C, Szakács G, Váradi A,
Sarkadi B and Özvegy-Laczka C: Mutations of the central tyrosines
of putative cholesterol recognition amino acid consensus (CRAC)
sequences modify folding, activity, and sterol-sensing of the human
ABCG2 multidrug transporter. Biochim Biophys Acta. 1848:477–487.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ozvegy C, Váradi A and Sarkadi B:
Characterization of drug transport, ATP hydrolysis, and nucleotide
trapping by the human ABCG2 multidrug transporter. Modulation of
substrate specificity by a point mutation. J Biol Chem.
277:47980–47990. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tschantz WR, Pfeifer ND, Meade CL, Wang L,
Lanzetti A, Kamath AV, Berlioz-Seux F and Hashim MF: Expression,
purification and characterization of the human membrane transporter
protein OATP2B1 from Sf9 insect cells. Protein Expr Purif.
57:163–171. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Patik I, Székely V, Német O, Szepesi Á,
Kucsma N, Várady G, Szakács G, Bakos É and Özvegy-Laczka C:
Identification of novel cell-impermeant fluorescent substrates for
testing the function and drug interaction of Organic
Anion-transporting polypeptides, OATP1B1/1B3 and 2B1. Sci Rep.
8:26302018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tusnády GE and Simon I: The HMMTOP
transmembrane topology prediction server. Bioinformatics.
17:849–850. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hagenbuch B and Meier PJ: The superfamily
of organic anion transporting polypeptides. Biochim Biophys Acta.
1609:1–18. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Thakkar N, Lockhart AC and Lee W: Role of
organic anion-transporting polypeptides (OATPs) in cancer therapy.
AAPS J. 17:535–545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kovacsics D, Patik I and Özvegy-Laczka C:
The role of organic anion transporting polypeptides in drug
absorption, distribution, excretion and drug-drug interactions.
Expert Opin Drug Metab Toxicol. 13:409–424. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sissung TM, Goey AK, Ley AM, Strope JD and
Figg WD: Pharmacogenetics of membrane transporters: A review of
current approaches. Methods Mol Biol. 1175:91–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Teft WA, Welch S, Lenehan J, Parfitt J,
Choi YH, Winquist E and Kim RB: OATP1B1 and tumour OATP1B3 modulate
exposure, toxicity, and survival after Irinotecan-based
chemotherapy. Br J Cancer. 112:857–865. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rhodes KE, Zhang W, Yang D, Press OA,
Gordon M, Vallböhmer D, Schultheis AM, Lurje G, Ladner RD, Fazzone
W, et al: ABCB1, SLCO1B1 and UGT1A1 gene polymorphisms are
associated with toxicity in metastatic colorectal cancer patients
treated with first-line irinotecan. Drug Metab Lett. 1:23–30. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Roth M, Obaidat A and Hagenbuch B: OATPs,
OATs and OCTs: The organic anion and cation transporters of the
SLCO and SLC22A gene superfamilies. Br J Pharmacol. 165:1260–1287.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Aslibekyan S, Brown EE, Reynolds RJ,
Redden DT, Morgan S, Baggott JE, Sha J, Moreland LW, O'Dell JR,
Curtis JR, et al: Genetic variants associated with methotrexate
efficacy and toxicity in early rheumatoid arthritis: Results from
the treatment of early aggressive rheumatoid arthritis trial.
Pharmacogenomics J. 14:48–53. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Eektimmerman F, Swen JJ, Böhringer S,
Aslibekyan S, Allaart CF and Guchelaar HJ: SLC04A1, SLC22A2 and
SLC28A2 variants not related to methotrexate efficacy or toxicity
in rheumatoid arthritis patients. Pharmacogenomics. 19:613–619.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fairley S, Lowy-Gallego E, Perry E and
Flicek P: The International Genome sample resource (IGSR)
collection of open human genomic variation resources. Nucleic Acids
Res. 48:D941–D947. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Durmus S, Lozano-Mena G, van Esch A,
Wagenaar E, van Tellingen O and Schinkel AH: Preclinical mouse
models to study human OATP1B1- and OATP1B3-mediated drug-drug
interactions in vivo. Mol Pharm. 12:4259–4269. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Alam K, Crowe A, Wang X, Zhang P, Ding K,
Li L and Yue W: Regulation of organic anion transporting
polypeptides (OATP) 1B1- and OATP1B3-mediated transport: An updated
review in the context of OATP-mediated drug-drug interactions. Int
J Mol Sci. 19:E8552018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Crowe A, Zheng W, Miller J, Pahwa S, Alam
K, Fung KM, Rubin E, Yin F, Ding K and Yue W: Characterization of
plasma membrane localization and phosphorylation status of organic
anion transporting polypeptide (OATP) 1B1 c.521 T>C
nonsynonymous single-nucleotide polymorphism. Pharm Res.
36:1012019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gui C and Hagenbuch B: Amino acid residues
in transmembrane domain 10 of organic anion transporting
polypeptide 1B3 are critical for cholecystokinin octapeptide
transport. Biochemistry. 47:9090–9097. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Meier-Abt F, Mokrab Y and Mizuguchi K:
Organic anion transporting polypeptides of the OATP/SLCO
superfamily: Identification of new members in nonmammalian species,
comparative modeling and a potential transport mode. J Membr Biol.
208:213–227. 2005. View Article : Google Scholar : PubMed/NCBI
|
